Abstract:Circulation Research, Ahead of Print. Background:Increasing evidence suggests that long noncoding RNAs play significant roles in vascular biology and disease development. One such long noncoding RNA,PSMB8-AS1, has been implicated in the development of tumors. Nevertheless, the precise role ofPSMB8-AS1in cardiovascular diseases, particularly atherosclerosis, has not been thoroughly elucidated. Thus, the primary aim of this investigation is to assess the influence ofPSMB8-AS1on vascular inflammation and the initiation of atherosclerosis.Methods:We generatedPSMB8-AS1knockin andApoe(Apolipoprotein E) knockout mice (Apoe−/−PSMB8-AS1KI) and globalApoeand proteasome subunit-β type-9 (Psmb9) double knockout mice (Apoe−/−Psmb9−/−). To explore the roles ofPSMB8-AS1andPsmb9in atherosclerosis, we fed the mice with a Western diet for 12 weeks.Results:Long noncoding RNAPSMB8-AS1is significantly elevated in human atherosclerotic plaques. Strikingly,Apoe−/−PSMB8-AS1KImice exhibited increased atherosclerosis development, plaque vulnerability, and vascular inflammation compared withApoe−/−mice. Moreover, the levels of VCAM1 (vascular adhesion molecule 1) and ICAM1 (intracellular adhesion molecule 1) were significantly upregulated in atherosclerotic lesions and serum ofApoe−/−PSMB8-AS1KImice. Consistently, in vitro gain- and loss-of-function studies demonstrated thatPSMB8-AS1induced monocyte/macrophage adhesion to endothelial cells and increased VCAM1 and ICAM1 levels in a PSMB9-dependent manner. Mechanistic studies revealed thatPSMB8-AS1inducedPSMB9transcription by recruiting the transcription factor NONO (non-POU domain-containing octamer-binding protein) and binding to thePSMB9promoter. PSMB9 (proteasome subunit-β type-9) elevated VCAM1 and ICAM1 expression via the upregulation of ZEB1 (zinc finger E-box-binding homeobox 1).Psmb9deficiency decreased atherosclerotic lesion size, plaque vulnerability, and vascular inflammation inApoe−/−mice in vivo. Importantly, endothelial overexpression ofPSMB8-AS1-increased atherosclerosis and vascular inflammation were attenuated byPsmb9knockout.Conclusions:PSMB8-AS1promotes vascular inflammation and atherosclerosis via the NONO/PSMB9/ZEB1 axis. Our findings support the development of new long noncoding RNA–based strategies to counteract atherosclerotic cardiovascular disease.

Long non-coding RNA RP11-490M8.1 inhibits lipopolysaccharide-induced pyroptosis of human umbilical vein endothelial cells via the TLR4/NF-κB pathway

Downregulation of activating transcription factor 4 attenuates lysophosphatidycholine-induced inflammation via the NF-κB pathway.

CircRNA-DAPK1 promotes vascular cell pyroptosis in diabetes by regulating the circ-DAPK1/miR-4454/TXNIP axis.

LncRNA-RP11-714G18.1 Suppresses Vascular Cell Migration Via Directly Targeting LRP2BP

Inhibiting microRNA-200a-3p attenuates pyroptosis via targeting the SIRT1/NF-κB/NLRP3 pathway in H2O2-induced HAEC

LncRNA NEAT1 Promotes TLR4 Expression to Regulate Lipopolysaccharide-Induced Trophoblastic Cell Pyroptosis as a Molecular Sponge of miR-302b-3p

Linc00657 promoted pyroptosis in THP-1-derived macrophages and exacerbated atherosclerosis via the miR-106b-5p/TXNIP/NLRP3 axis

MiR-155 is Involved in Renal Ischemia-Reperfusion Injury via Direct Targeting of FoxO3a and Regulating Renal Tubular Cell Pyroptosis.

LncRNA FAF Attenuates Hypoxia/ischaemia-Induced Pyroptosis Via the Mir-185-5p/pak2 Axis in Cardiomyocytes

Knockdown of long non-coding RNA plasmacytoma variant translocation 1 relieves ox-LDL-induced endothelial cell injury through regulating microRNA-30c-5p in atherosclerosis

MicroRNA-146a-5p alleviates lipopolysaccharide-induced NLRP3 inflammasome injury and pro-inflammatory cytokine production via the regulation of TRAF6 and IRAK1 in human umbilical vein endothelial cells (HUVECs)

LncRNA‐HOTAIR Promotes Endothelial Cell Pyroptosis by Regulating the Mir‐22/nlrp3 Axis in Hyperuricaemia

Autophagy blockage promotes the pyroptosis of ox-LDL-treated macrophages by modulating the p62/Nrf2/ARE axis

Long noncoding RNA ZNF800 suppresses proliferation and migration of vascular smooth muscle cells by upregulating PTEN and inhibiting AKT/mTOR/HIF-1α signaling

LncRNA ROR promotes NLRP3-mediated cardiomyocyte pyroptosis by upregulating FOXP1 via interactions with PTBP1

Retinol‐Binding Protein 4 Promotes Cardiac Injury After Myocardial Infarction Via Inducing Cardiomyocyte Pyroptosis Through an Interaction With NLRP3

LncRNA PSMB8-AS1 Instigates Vascular Inflammation to Aggravate Atherosclerosis

LncRNA 220 , a newly discovered long non-conding RNA inhibiting apoptosis and autophagy in Kupffer cells in LPS-induced endotoxemic mice through the XBP1u-PI3K-AKT pathway

Pyroptosis is a critical immune-inflammatory response involved in atherosclerosis

Roles of pyroptosis in atherosclerosis pathogenesis

LncRNA NIPA1-SO confers atherosclerotic protection by suppressing the transmembrane protein NIPA1